as well as the development of oocyte competence, and that of the subsequent embryo.
LH leads to negligible oestradiol production, even when FSH There has been much debate about the role of luteinizing can stimulate follicular growth (Couzinet et al., 1988) . In fact, hormone (LH) during follicle stimulating hormone (FSH)-it has been proposed that the latter stages of follicular growth treated ovarian stimulation for assisted reproduction, where in women, may be induced by FSH alone (Loumaye et al. , the endogenous LH is suppressed using a gonadotrophin-1997). However, the results of a recent multicentre study with releasing hormone analogue. The requirement for LH in recombinant FSH (rFSH) and recombinant LH (rLH) treatment oestradiol biosynthesis is established, but other effects of of women with hypogonadotrophic hypogonadism, suggested 'insufficiency' are less clear, and little attention has been that LH actually sensitizes follicles to FSH, and thereby paid to the specific origin of the FSH used. The aim of this encourages follicular development as well as hormone secretion study was to examine the roles of profoundly suppressed (ERHLHSG, 1998) . The number of follicles developing after circulating LH concentrations in cycles of ovarian stimulaa fixed dose of rFSH was much reduced or delayed in the tion for IVF, which were affected in two large separate group treated without rLH. The dose of 75 IU rLH per day cohorts of patients undergoing assisted reproduction. They appeared to be sufficient to facilitate most functions of follicular were stimulated by either purified urinary FSH (MHP) or development.
recombinant human FSH (rFSH). Within each dataset,
A role of LH at other levels of ovarian function may be outcomes were examined with respect to the circulating implied by two other lines of evidence. In an in-vitro small concentrations of LH in the mid-follicular phase, as plasma mammal model, the importance of the interaction between LH samples were stored prospectively, and assayed retrospectand the theca cell mass in physiological events as well as ively. Patients with profoundly suppressed LH showed follicular endocrinology has been highlighted (Cortvrindt et al. , much reduced oestradiol concentrations at mid-follicular 1998). Mouse follicles cultured in the presence of rFSH without phase and at human chorionic gonadotrophin administrarLH clearly demonstrated a reduced rate of antrum formation, tion in cycles treated with either MHP or rFSH. However, and oocyte nuclear maturation. In sheep follicular cells and gross ovarian response, as became evident by FSH dose intact follicles cultured in vitro, LH was seen to be obligatory demands, duration of stimulation, and also oocyte and for the production of specific polypeptides seen in vivo (Moor embryo yields and embryo cryopreservation were influ and Crosby, 1987) . enced only in cycles treated with MHP. Furthermore, no
Further evidence derives from a woman with hypogonadoeffect upon pregnancy survival was observed. Thus, it is trophic hypogonadism undergoing IVF after treatment with concluded that there is a demand for additional exogenous purified FSH or FSH combined with additional oestradiol, in LH treatment only in cycles treated with purified urinary which oocytes were obtained which showed poor fertilization FSH where the LH is profoundly suppressed.
rates. The same individual was subsequently treated with Key words: follicle stimulating hormone/follicular growth/ combined FSH and LH (human menopausal gonadotrophin; gonadotrophins/luteinising hormone/ovarian stimulation HMG), and the oocytes showed normal fertilization rates. These data suggest that the LH-depleted environment may yield oocytes with a reduced potential for further development (Balasch et al., 1995) .
Introduction
Further evidence for LH activity during the follicular phase having an impact upon oocyte/embryo competence was proThere is evidence supporting roles for LH in three particular functions in the life history of human ovarian follicles prior vided by studies in macaque monkeys in which LH was suppressed using a gonadotrophin-releasing hormone antagonto luteinization. The clearest evidence supports a well-defined and direct role for LH in steroid biosynthesis, but it may also ist, and follicular growth stimulated with rFSH or rFSH with rLH. Reasonable follicular growth and oocyte yields were be capable of influencing the dynamics of follicular growth, obtained after stimulation with rFSH alone, and higher fertilizaMaterials and methods tion rates were obtained with rFSH compared with the combina-
Patients and treatment
tion of rFSH and rLH (Zelinski-Wooten et al., 1996) . However, All patients were nulliparous with a minimum duration of infertility the absence of rLH had a detrimental effect upon embryo of 3 years, and they underwent IVF in the assisted conception clinic cryosurvival, development and implantation after cryopreservat the Royal Infirmary, Glasgow. ation and thawing (Weston et al., 1996) . These data imply that In the clinical situation of assisted reproduction, the three effected on stimulation day 7 (S7), when dose titration was effected.
most important criteria are numbers of oocytes obtained If the oestradiol concentration was Ͻ200 pg/ml the dose was increased, after a course of ovarian stimulation, their developmental whereas if the oestradiol value was Ͼ1000 pg/ml the dose was competence, and the ability of implanted embryos to sustain reduced to 150 IU. The luteinizing signal of human chorionic viable fetal development.
gonadotrophin (HCG, Profasi; Serono UK Ltd, Welwyn Garden City, It is clear that the widespread use of urinary FSH or UK: 10 000 IU) was administered only when there were more purified urinary FSH, without LH supplementation in ovarian than two mature sized follicles (diameter Ͼ16 mm) observed by ultrasonography. Oocyte retrieval was effected 37-40 h after HCG stimulation, has not led to a drop in overall programme success administration. Cycles were cancelled for 'poor response' after 5 rates, and it has been suggested that there is no need to explore days continued treatment with the increased dose without attaining, or the requirement for LH supplementation further (Hull et al., the imminent prospect of attaining, the criteria for HCG administration.
1994). However, different hormone profiles have been recorded
Embryo cryopreservation was effected when there were more than according to LH activity in the stimulant and/or in the one 'good quality' embryos available after the fresh embryo transfer. In circulation (Fleming et al., 1996; Fried et al., 1996) , and the order to reduce the risks and consequences of ovarian hyperstimulation exploration of other possible effects of LH depletion after syndrome, cases with Ͼ16 oocytes recovered did not receive a fresh gonadotrophin-releasing hormone analogue (GnRHa) co-treatembryo transfer, as all embryos were cryopreserved for transfer in a ment have been rare. Two prospective studies were performed subsequent cycle.
to examine the effects of profoundly suppressed LH during Treatment and hormone assays the follicular phase of COS cycles. The results indicated that when purified, urinary FSH was used, profound suppression Furthermore, all first treatment cycles were examined in isolation, as only within the groups. There was no difference in fertilization they represented an unbiased cohort and had a common starting dose rates, nor in the proportion of cycles in which all embryos were (universally 225 IU FSH per day, for at least 6 days) and response cryopreserved in order to reduce the risk of ovarian hyperstimuassessment. lation syndrome.
Statistical analyses

First treatment cycles only
Due to changes in practice, and the non-randomized treatment sched- Tables III and IV examine the extracted data for first treatment ules, the data could only be compared within databases based upon cycles only from the same datasets as those above. This avoids the discriminating LH value. Hormone concentrations were compared the bias of individuals being represented more than once, and a using t-tests, and group comparisons were compared using contingency consistent and universal starting dose of FSH (225 IU/l) was table analyses. Data were deemed to be significantly different when P used in these cases. Unlike the complete data sets, the MHP-ഛ 0.05, and 'marginally' significant when P ഛ 0.08 and P Ͼ 0.05. treated cycles with reduced circulating LH concentrations showed significantly higher rates of cycle cancellation due to Results poor response. They also showed higher rates of increased daily doses, and a greater duration of treatment, as in the complete The complete data sets data sets. As previously, these differences were not observed in Table I shows the numbers of cycles and the ages of the patients the Gonal-F-treated cycles. This contrasted with the differences as well as the stimulation data for the patient cycles in each in circulating oestradiol at S7 and at HCG administration, where database. The cycles with suppressed follicular phase LH (MHP significant differences were observed in both treatment groups. Ͻ LH, and GOF Ͻ LH) showed the same age profiles as their
The effects of profoundly suppressed LH upon gross ovarian counterparts with normal LH values (nLH), and they had much yield were similar to those of the complete data sets, although reduced circulating oestradiol concentrations at S7 and at HCG the tendency towards a reduced yield of oocytes (Table IV) was administration in both groups of patients, compared with those not significant. In both complete data sets and first treatment whose LH was Ͼ 0.7 IU/l. With respect to the proportions of cycles only, there was a profound reduction in cases with cryopcycles cancelled due to poor response, there was no difference reserved embryos which were only detected in the group treated according to LH status within either database or between the with MHP. two databases, with respect to the circulating LH concentration. However, the proportions of cases showing dose increases were Early pregnancy loss higher in the MHP Ͻ LH patients compared with the MHP- Table V shows that there was no difference in the rate of early nLH group. The duration of stimulation also was significantly pregnancy loss in the patients, irrespective of ovarian stimulant increased in the MHP Ͻ LH group. Neither of these variables used or the circulating LH. Combining the two databases showed differences when the stimulant was Gonal-F. revealed no effect of suppressed follicular phase LH at this level Table II shows the ovarian and embryological details in the of embryo development. Cases were included where conception two groups of patients. Only the MHP Ͻ LH group showed an occurred after fresh embryo transfer during the cycle of stimulaeffect of suppressed LH upon gross ovarian yield. The data tion and ectopic pregnancies were excluded. indicate a clear effect upon the yield of oocytes, which showed consequences upon the numbers of embryos and cases with Discussion embryo cryopreservation. The policies for embryo cryopreservation were not the same during the periods constituting the two
The results confirmed that reduced circulating LH concentrations are associated with lower oestradiol concentrations in databases, so results cannot be compared between the datasets - Table I . Table IV . Gross ovarian yields in the first treatment cycles in the two groups of patients in the two databases. The patients were treated with Metrodin High Purity (MHP) or Gonal-F (GOF) and divided into groups dictated by the circulating mid-follicular phase LH concentration Table I. ovarian stimulation cycles for IVF, irrespective of whether the detrimental effect of suppressed LH leading to a reduced oocyte yield previously recorded in a prospective study with FSH derives from purified urinary or recombinant sources. The observation of a longer treatment duration combined with selective patient recruitment (Fleming et al., 1998) was also observed in a complete treatment programme. This effect had a reduced oocyte yield in the MHP Ͻ LH group indicated a clear impact of profound suppression of LH upon ovarian further consequences upon the treatment cycle, as fewer embryos were available for cryopreservation for the group responses in women treated with ovarian stimulation where the stimulant is purified, urinary FSH. This confirms that the with suppressed LH. However, no effect of profound LH There were no significant differences between the two groups. For definition of groups see Table I. suppression upon gross ovarian yields was determined in 1994). Thus, low amounts of LH activity may contribute to the overall potency of an FSH preparation, as well as helping cycles treated with rFSH.
The effect of a reduced yield of oocytes in the MHP Ͻ LH provide more androgen precursor for oestradiol biosynthesis. Therefore it is possible that differences in the effects of cases was reflected in the lower proportion of cycles in the MHP Ͻ LH group with embryo cryopreservation. This clearly profound suppression of LH on ovarian responses in the two treatment schedules may be explained by differences in potency impacts upon the pregnancy potential of a treatment cycle. But again, there was no such effect in cycles treated with alone. The urinary FSH (MHP) may be less potent than the rFSH, but the low concentrations of LH remaining in the rFSH. To some degree the local treatment protocol influenced these results, since embryo cryopreservation was only affected circulation may compensate for the 'shortfall', while the rFSH is sufficiently potent to obviate the need for LH, except in its when there was more than one quality of embryo available (data not shown). Thus the relatively small effect upon oocyte function of providing precursors for oestradiol biosynthesis. Pregnancy rates with different drug treatment regimes have yield had a more profound effect upon embryo cryopreservation in the MHP Ͻ LH group. Although there was no effect of the been addressed in other studies, with larger scope and formal randomization, with the general indication that treatment with LH suppression upon embryo scores (data not shown) the frequency of sufficient embryos of sufficient quality was FSH alone does not reduce pregnancy rates (Out et al., 1995) in IVF programmes where rFSH is used as the ovarian critical to the cryopreservation data.
Ovarian hyperstimulation syndrome is a suitable candidate stimulant. However, pregnancy loss has not been explored with respect to suppressed follicular phase LH. Despite much for analyses in database examinations such as these, especially as effects upon oestradiol concentrations have been observed, interest in the role of excessive LH in early pregnancy loss (Homburg et al., 1988) , there has been no investigation into but the data were deemed unsuitable for comparisons within this context. This is because of the intrinsic bias incurred by the effects of profound LH suppression into the viability of pregnancies achieved under these controlled conditions. If the unit policy to cryopreserve all embryos when excessive numbers are retrieved, and also patients often refer themselves excessive activation of the LH receptor has implications for pregnancy viability, then it is possible that insufficient activato other hospitals when in distress, such that reliable diagnoses and recording are not available.
tion may be damaging also. It has already been reported that the implantation potential The carbohydrate composition of rFSH, and consequently the isoform profile of rFSH, is different from that of highly of cryopreserved embryos was not affected by profound follicular phase LH suppression (Rehka et al., 1998 ) and purified FSH, and studies in vivo (Out et al., 1995) and in vitro (De Leeuw et al., 1996) have suggested that rFSH is furthermore that fresh blastocyst development in vitro was also unaffected (Fleming et al., 1998) . Pregnancy survival also more potent than urinary-derived FSH in this clinical situation. In the data presented above, the oestradiol responses to appears to be unaffected by LH suppression, at least in the results from these two datasets (Table V) . stimulation were affected equally by the LH designation in both treatment databases, reflecting the direct role of LH
In conclusion, the data demonstrate that the impact of profound LH suppression depends upon the origin of the FSH, in oestradiol biosynthesis. However, with rFSH treatment, suppression of LH failed to show the impact upon gross and that clinical implications may only apply when the ovarian stimulant is purified urinary FSH. In women with ovarian responses that were evident with purified urinary FSH (MHP).
hypogonadotrophic hypogonadism, LH can be seen to sensitize follicles to FSH for recruitment and growth, as well as Both FSH and LH induce increases in intracellular cyclic AMP (cAMP) activity in unluteinized follicular granulosa oestradiol secretion (ERHLHSG, 1998) . However, although the degree of LH suppression achieved in ovarian stimulation cells, and both are capable of stimulating aromatase activity. In fact, in mature granulosa cells, LH is more potent in the cycles does not normally reach that of true hypogonadotrophic hypogonadism, similar effects based on potency can be detected role of stimulating the cAMP internal messenger (Yong et al., 
